Concord Medical Services (CCM)
(Delayed Data from NYSE)
$5.53 USD
+0.07 (1.28%)
Updated Sep 19, 2024 02:40 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
CCM 5.53 +0.07(1.28%)
Will CCM be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CCM based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for CCM
Canagold Completes Resource Expansion Drilling Program at New Polaris with Additional Strong Mineralization Intercepts
Canagold Announces Promising Drilling Results at New Polaris
Concord Medical secures large medical equipment procurement license for proton therapy equipment
Concord Medical Announces Obtaining Large Medical Equipment Procurement License for Its Proton Therapy Equipment
Concord Medical Secures Key Equipment License